Perfluoroalkyl acids in maternal serum and indices of fetal growth: The aarhus birth cohort

Environmental Health Perspectives

Volumn 124, Issue 6, 2016, Pages 848-854

  Bach, Cathrine Carlsen ^a,b   Bech, Bodil Hammer ^c   Nohr, Ellen Aagaard ^d   Olsen, Jørn ^c,e   Matthiesen, Niels Bjerregård ^a   Bonefeld Jørgensen, Eva Cecilie ^c   Bossi, Rossana ^c   Henriksen, Tine Brink ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HORSENS REGIONAL HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUOROHEXANESULFONIC ACID; PERFLUOROOCTANESULFONIC ACID; ALKANESULFONIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE; PERFLUOROOCTANOIC ACID; POLLUTANT;

ADULT; ARTICLE; BIRTH WEIGHT; DRUG EXPOSURE; FEMALE; FETUS GROWTH; GESTATIONAL AGE; GLOMERULUS FILTRATION RATE; HEALTH CARE PERSONNEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF QUANTITATION; MALE; MATERNAL SERUM; PREGNANT WOMAN; PRIORITY JOURNAL; QUESTIONNAIRE; TANDEM MASS SPECTROMETRY; BLOOD; DRUG EFFECTS; FETUS DEVELOPMENT; MATERNAL EXPOSURE; POLLUTANT; PREGNANCY; STATISTICS AND NUMERICAL DATA;

ADULT; ALKANESULFONIC ACIDS; BIRTH WEIGHT; CAPRYLATES; ENVIRONMENTAL POLLUTANTS; FEMALE; FETAL DEVELOPMENT; FLUOROCARBONS; HUMANS; MATERNAL EXPOSURE; PREGNANCY;

EID: 84971505200     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1510046     Document Type: Article

References (59)

1. Abbott BD. 2009. Review of the expression of peroxisome proliferator-activated receptors alpha (PPARα), beta (PPARβ), and gamma (PPARγ) in rodent and human development. Reprod Toxicol 27: 246-257, doi: 10. 1016/j. reprotox. 2008. 10. 001.
2. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. 1996. A United States national reference for fetal growth. Obstet Gynecol 87: 163-168, doi: 10. 1016/0029-7844(95)00386-X.
3. Andersen CS, Fei C, Gamborg M, Nohr EA, Sørensen TIA, Olsen J. 2010. Prenatal exposures to perfluorinated chemicals and anthropometric measures in infancy. Am J Epidemiol 172: 1230-1237, doi: 10. 1093/aje/kwq289.
4. Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, et al. 2007. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 115: 1670-1676, doi: 10. 1289/ehp. 10334.
5. Arbuckle TE, Kubwabo C, Walker M, Davis K, Lalonde K, Kosarac I, et al. 2013. Umbilical cord blood levels of perfluoroalkyl acids and polybrominated flame retardants. Int J Hyg Environ Health 216: 184-194, doi: 10. 1016/j. ijheh. 2012. 03. 004.
6. Bach CC, Bech BH, Brix N, Nohr EA, Bonde JPE, Henriksen TB. 2015. Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: a systematic review. Crit Rev Toxicol 45: 53-67, doi: 10. 3109/10408444. 2014. 952400.
7. Benninghoff AD, Bisson WH, Koch DC, Ehresman DJ, Kolluri SK, Williams DE. 2011. Estrogen-like activity of perfluoroalkyl acids in vivoand interaction with human and rainbow trout estrogen receptors in vitro. Toxicol Sci 120: 42-58.
8. Buck Louis GM, Sundaram R, Schisterman EF, Sweeney AM, Lynch CD, Gore-Langton RE, et al. 2013. Persistent environmental pollutants and couple fecundity: the LIFE Study. Environ Health Perspect 121: 231-236, doi: 10. 1289/ehp. 1205301.
9. Butenhoff JL, Olsen GW, Pfahles-Hutchens A. 2006. The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum. Environ Health Perspect 114: 1776-1782, doi: 10. 1289/ehp. 9060.
10. Chen MH, Ha EH, Wen TW, Su YN, Lien GW, Chen CY, et al. 2012. Perfluorinated compounds in umbilical cord blood and adverse birth outcomes. PLoS One 7: e42474, doi: 10. 1371/journal. pone. 0042474.
11. Darrow LA, Howards PP, Winquist A, Steenland K. 2014. PFOA and PFOS serum levels and miscarriage risk. Epidemiology 25: 505-512, doi: 10. 1097/ EDE. 0000000000000103.
12. Darrow LA, Stein CR, Steenland K. 2013. Serum perfluoro octanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio Valley, 2005-2010. Environ Health Perspect 121: 1207-1213, doi: 10. 1289/ehp. 1206372.
13. Du G, Hu J, Huang H, Qin Y, Han X, Wu D, et al. 2013. Perfluorooctane sulfonate (PFOS) affects hormone receptor activity, steroidogenesis, and expression of endocrine-related genes in vitro and in vivo. Environ Toxicol Chem 32: 353-360, doi: 10. 1002/etc. 2034.
14. Environment Canada. 2010. Environmental Performance Agreement ("Agreement") Respecting Perfluorinated Carboxylic Acids (Pfcas) and their Precursors in Perfluorochemical Products Sold in Canada. Available: http: //www. ec. gc. ca/epe-epa/AE06B51E-7BB7-4C92-A4B5-6027E9195712/PFCA_EPA-EN. pdf [accessed 2 January 2015].
15. European Parliament. 2006. Directive 2006/122/EC of the European Parliament and of the Council of 12 December 2006 amending for the 30th time Council Directive 76/769/EEC on the approximation of the laws, regulations and administrative provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations (perfluorooctane sulfonates). Official Journal of the European Union L372/32-L372/34.
16. Fei C, McLaughlin JK, Lipworth L, Olsen J. 2009. Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod 24: 1200-1205, doi: 10. 1093/humrep/den490.
17. Fei C, McLaughlin JK, Tarone RE, Olsen J. 2007. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 115: 1677-1682, doi: 10. 1289/ehp. 10506.
18. Glynn A, Berger U, Bignert A, Ullah S, Aune M, Lignell S, et al. 2012. Perfluorinated alkyl acids in blood serum from primiparous women in Sweden: serial sampling during pregnancy and nursing, and temporal trends 1996-2010. Environ Sci Technol 46(16): 9071-9079, doi: 10. 1021/es301168c.
19. Hamm MP, Cherry NM, Chan E, Martin JW, Burstyn I. 2010. Maternal exposure to perfluorinated acids and fetal growth. J Expo Sci Environ Epidemiol 20: 589-597, doi: 10. 1038/jes. 2009. 57.
20. Henry ND, Fair PA. 2011. Comparison of in vitrocytotoxicity, estrogenicity and anti-estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid. J Appl Toxicol 33: 265-272.
21. Inoue K, Okada F, Ito R, Kato S, Sasaki S, Nakajima S, et al. 2004. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 112: 1204-1207, doi: 10. 1289/ehp. 6864.
22. Jensen TK, Andersen LB, Kyhl HB, Nielsen F, Christesen HT, Grandjean P. 2015. Association between perfluorinated compound exposure and miscarriage in Danish pregnant women. PloS One 10: e0123496, doi: 10. 1371/journal. pone. 0123496.
23. Jørgensen KT, Specht IO, Lenters V, Bach CC, Rylander L, Jönsson BA, et al. 2014. Perfluoroalkyl substances and time to pregnancy in couples from Greenland, Poland and Ukraine. Environ Health 13: 116, doi: 10. 1186/1476-069X-13-116.
24. Kantiani L, Llorca M, Sanchís J, Farré M, Barceló D. 2010. Emerging food contaminants: a review. Anal Bioanal Chem 398: 2413-2427, doi: 10. 1007/ s00216-010-3944-9.
25. Kim S, Choi K, Ji K, Seo J, Kho Y, Park J, et al. 2011. Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. Environ Sci Technol 45: 7465-7472, doi: 10. 1021/es202408a.
26. Kishi R, Nakajima T, Goudarzi H, Kobayashi S, Sasaki S, Okada E, et al. 2015. The association of prenatal exposure to perfluorinated chemicals with maternal essential and long-chain polyunsaturated fatty acids during pregnancy and the birth weight of their offspring: the Hokkaido Study. Environ Health Perspect 123: 1038-1045, doi: 10. 1289/ehp. 1408834.
27. Kjeldsen LS, Bonefeld-Jørgensen EC. 2013. Perfluorinated compounds affect the function of sex hormone receptors. Environ Sci Pollut Res Int 20: 8031-8044, doi: 10. 1007/s11356-013-1753-3.
28. Koustas E, Lam J, Sutton P, Johnson PI, Atchley DS, Sen S, et al. 2014. The Navigation Guide-evidence-based medicine meets environmental health: systematic review of nonhuman evidence for PFOA effects on fetal growth. Environ Health Perspect 122: 1015-1027, doi: 10. 1289/ehp. 1307177
29. Larsen PS, Kamper-Jørgensen M, Adamson A, Barros H, Bonde JP, Brescianini S, et al. 2013. Pregnancy and birth cohort resources in Europe: a large opportunity for aetiological child health research. Paediatr Perinat Epidemiol 27: 393-414, doi: 10. 1111/ppe. 12060.
30. Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, et al. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci 74: 382-392, doi: 10. 1093/toxsci/kfg122.
31. Lee YJ, Kim MK, Bae J, Yang JH. 2013. Concentrations of perfluoroalkyl compounds in maternal and umbilical cord sera and birth outcomes in Korea. Chemosphere 90: 1603-1609, doi: 10. 1016/j. chemosphere. 2012. 08. 035.
32. Liew Z, Olsen J, Cui X, Ritz B, Arah OA. 2015. Bias from conditioning on live birth in pregnancy cohorts: an illustration based on neurodevelopment in children after prenatal exposure to organic pollutants. Int J Epidemiol 44: 345-354, doi: 10. 1093/ije/dyu249.
33. Liew Z, Ritz B, Bonefeld-Jørgensen EC, Henriksen TB, Nohr EA, Bech BH, et al. 2014. Prenatal exposure to perfluoroalkyl substances and the risk of congenital cerebral palsy in children. Am J Epidemiol 180: 574-581, doi: 10. 1093/aje/kwu179.
34. Loccisano AE, Longnecker MP, Campbell JL Jr, Andersen ME, Clewell HJ III. 2013. Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages. J Toxicol Environ Health A 76(1): 25-57, doi: 10. 1080/15287394. 2012. 722523.
35. Long M, Ghisari M, Bonefeld-Jørgensen EC. 2013. Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor. Environ Sci Pollut Res Int 20: 8045-8056, doi: 10. 1007/s11356-013-1628-7.
36. Luebker DJ, York RG, Hansen KJ, Moore JA, Butenhoff JL. 2005. Neonatal mortality from in utero exposure to perfluorooctane sulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharmacokinetic parameters. Toxicology 215: 149-169.
37. Maisonet M, Terrell ML, McGeehin MA, Christensen KY, Holmes A, Calafat AM, et al. 2012. Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls. Environ Health Perspect 120: 1432-1437, doi: 10. 1289/ ehp. 1003096.
38. Marsál K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. 1996. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 85: 843-848.
39. Midasch O, Drexler H, Hart N, Beckmann MW, Angerer J. 2007. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health 80: 643-648, doi: 10. 1007/s00420-006-0165-9.
40. Monroy R, Morrison K, Teo K, Atkinson S, Kubwabo C, Stewart B, et al. 2008. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 108: 56-62, doi: 10. 1016/j. envres. 2008. 06. 001.
41. Morken NH, Travlos GS, Wilson RE, Eggesbø M, Longnecker MP. 2014. Maternal glomerular filtration rate in pregnancy and fetal size. PLoS One 9(7): e101897, doi: 10. 1371/journal. pone. 0101897.
42. Mortensen LM, Bech BH, Nohr EA, Kruhøffer M, Kjærgaard S, Uldbjerg N, et al. 2013. Data resource profile: the Aarhus Birth Cohort Biobank (ABC Biobank). Int J Epidemiol 42: 1697-1701, doi: 10. 1093/ ije/dyt199.
43. Robledo CA, Yeung E, Mendola P, Sundaram R, Maisog J, Sweeney AM, et al. 2015. Preconception maternal and paternal exposure to persistent organic pollutants and birth size: the LIFE Study. Environ Health Perspect 123: 88-94, doi: 10. 1289/ ehp. 1308016.
44. Savitz DA, Stein CR, Bartell SM, Elston B, Gong J, Shin HM, et al. 2012a. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community. Epidemiology 23: 386-392, doi: 10. 1097/EDE. 0b013e31824cb93b.
45. Savitz DA, Stein CR, Elston B, Wellenius GA, Bartell SM, Shin HM, et al. 2012b. Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the mid-Ohio Valley. Environ Health Perspect 120: 1201-1207, doi: 10. 1289/ehp. 1104752.
46. Stein CR, Savitz DA, Dougan M. 2009. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am J Epidemiol 170: 837-846, doi: 10. 1093/aje/kwp212.
47. Takahashi M, Ishida S, Hirata-Koizumi M, Ono A, Hirose A. 2014. Repeated dose and reproductive/ developmental toxicity of perfluoroundecanoic acid in rats. J Toxicol Sci 39(1): 97-108.
48. Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, et al. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci 74: 369-381, doi: 10. 1093/toxsci/kfg121.
49. UNEP (United Nations Environment Programme). 2009. Governments Unite to Step-up Reduction on Global DDT Reliance and Add Nine New Chemicals under International Treaty. Available: http: //chm. pops. int/Convention/Pressrelease/ COP4Geneva8May2009/tabid/542/language/en-US/ Default. aspx [accessed 2 January 2015].
50. U. S. EPA (U. S. Environmental Protection Agency). 2000. EPA and 3M Announce Phase Out of PFOS. Available: http: //yosemite. epa. gov/opa/admpress. nsf/0/33aa946e6cb11f35852568e1005246b4 [accessed 2 January 2015].
51. U. S. EPA. 2006. 2010/2015 PFOA Stewardship Program. Available: http: //www. epa. gov/assessing-andmanaging-chemicals-under-tsca/20102015-pfoastewardship-program[accessed 2 January 2015].
52. Vélez MP, Arbuckle TE, Fraser WD. 2015. Maternal exposure to perfluorinated chemicals and reduced fecundity: the MIREC Study. Hum Reprod 30: 701-709, doi: 10. 1093/humrep/deu350.
53. Vestergaard S, Nielsen F, Andersson AM, Hjøllund NH, Grandjean P, Andersen HR, et al. 2012. Association between perfluorinated compounds and time to pregnancy in a prospective cohort of Danish couples attempting to conceive. Hum Reprod 27: 873-880, doi: 10. 1093/humrep/der450.
54. Wang Y, Starling AP, Haug LS, Eggesbo M, Becher G, Thomsen C, et al. 2013. Association between perfluoroalkyl substances and thyroid stimulating hormone among pregnant women: a cross-sectional study. Environ Health 12: 76, doi: 10. 1186/1476-069X-12-76.
55. Washino N, Saijo Y, Sasaki S, Kato S, Ban S, Konishi K, et al. 2009. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect 117: 660-667, doi: 10. 1289/ehp. 11681.
56. Whitworth KW, Haug LS, Baird DD, Becher G, Hoppin JA, Skjaerven R, et al. 2012a. Perfluorinated compounds and subfecundity in pregnant women. Epidemiology 23: 257-263, doi: 10. 1097/ EDE. 0b013e31823b5031.
57. Whitworth KW, Haug LS, Baird DD, Becher G, Hoppin JA, Skjaerven R, et al. 2012b. Perfluorinated compounds in relation to birth weight in the Norwegian Mother and Child Cohort Study. Am J Epidemiol 175: 1209-1216, doi: 10. 1093/aje/kwr459.
58. Wilcox AJ, Weinberg CR, Basso O. 2011. On the pitfalls of adjusting for gestational age at birth. Am J Epidemiol 174: 1062-1068, doi: 10. 1093/aje/kwr230.
59. Wu K, Xu X, Peng L, Liu J, Guo Y, Huo X. 2012. Association between maternal exposure to perfluoro octanoic acid (PFOA) from electronic waste recycling and neonatal health outcomes. Environ Int 48: 1-8, doi: 10. 1016/j. envint. 2012. 06. 018